P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011)

J. E. Ledgerwood, L. Novik, M. E. Enama, I. J. Gordon, L. A. Holman, M. C. Nason, R. T. Bailer, M. Roederer, R. A. Koup, J. R. Mascola, G. J. Nabel, B. S. Graham

Research output: Contribution to journalArticle

Original languageEnglish (US)
Article number1742
JournalRetrovirology
Volume6
Issue numberSUPPL. 3
DOIs
StatePublished - Oct 22 2009
Externally publishedYes

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Ledgerwood, J. E., Novik, L., Enama, M. E., Gordon, I. J., Holman, L. A., Nason, M. C., Bailer, R. T., Roederer, M., Koup, R. A., Mascola, J. R., Nabel, G. J., & Graham, B. S. (2009). P14-10. Comparable immunogenicity of VRC DNA and rAd5 HIV-1 vaccines delivered by intramuscular, subcutaneous and intradermal routes in healthy adults (VRC 011). Retrovirology, 6(SUPPL. 3), [1742]. https://doi.org/10.1186/1742-4690-6-S3-P198